STAAR Surgical Company (STAA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, STAAR Surgical Company (STAA) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.67 Million) by net assets ($353.78 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
STAAR Surgical Company - Cash Flow Conversion Efficiency Trend (1990–2024)
This chart illustrates how STAAR Surgical Company's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read STAAR Surgical Company total liabilities for a breakdown of total debt and financial obligations.
STAAR Surgical Company Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of STAAR Surgical Company ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ji'an Mankun Technology Co. Ltd. A
SHE:301132
|
0.015x |
|
Beingmate Baby & Child Food Co Ltd
SHE:002570
|
0.012x |
|
CSBC Corp Taiwan
TW:2208
|
-0.528x |
|
Tejas Networks Limited
NSE:TEJASNET
|
-0.154x |
|
SAF Holland SA
XETRA:SFQ
|
0.157x |
|
Storytel AB (publ)
ST:STORY-B
|
0.099x |
|
Playtech plc
F:PL8
|
0.074x |
|
Regional Container Lines Public Company Limited
BK:RCL
|
0.053x |
Annual Cash Flow Conversion Efficiency for STAAR Surgical Company (1990–2024)
The table below shows the annual cash flow conversion efficiency of STAAR Surgical Company from 1990 to 2024. For the full company profile with market capitalisation and key ratios, see how much is STAAR Surgical Company worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $397.33 Million | $15.72 Million | 0.040x | +4.66% |
| 2023-12-31 | $385.95 Million | $14.59 Million | 0.038x | -64.41% |
| 2022-12-31 | $336.11 Million | $35.72 Million | 0.106x | -37.50% |
| 2021-12-31 | $258.56 Million | $43.96 Million | 0.170x | +60.06% |
| 2020-12-31 | $197.22 Million | $20.95 Million | 0.106x | -34.16% |
| 2019-12-31 | $159.88 Million | $25.80 Million | 0.161x | +67.35% |
| 2018-12-31 | $132.43 Million | $12.77 Million | 0.096x | +45.09% |
| 2017-12-31 | $42.94 Million | $2.85 Million | 0.066x | +140.10% |
| 2016-12-31 | $37.91 Million | $1.05 Million | 0.028x | +149.72% |
| 2015-12-31 | $38.85 Million | $-2.16 Million | -0.056x | +74.03% |
| 2014-12-31 | $37.10 Million | $-7.95 Million | -0.214x | -348.41% |
| 2013-12-31 | $38.85 Million | $3.35 Million | 0.086x | -14.87% |
| 2012-12-31 | $31.74 Million | $3.22 Million | 0.101x | -44.15% |
| 2011-12-31 | $29.46 Million | $5.35 Million | 0.181x | +192.14% |
| 2010-12-31 | $22.43 Million | $-4.42 Million | -0.197x | -390.80% |
| 2009-12-31 | $21.07 Million | $1.43 Million | 0.068x | +113.19% |
| 2008-12-31 | $16.03 Million | $-8.23 Million | -0.513x | -66.29% |
| 2007-12-31 | $36.23 Million | $-11.18 Million | -0.309x | -13.40% |
| 2006-12-31 | $31.76 Million | $-8.65 Million | -0.272x | -57.54% |
| 2005-12-31 | $40.37 Million | $-6.98 Million | -0.173x | +25.68% |
| 2004-12-31 | $37.86 Million | $-8.80 Million | -0.233x | -98.67% |
| 2003-12-31 | $35.42 Million | $-4.15 Million | -0.117x | -730.49% |
| 2002-12-31 | $30.65 Million | $569.00K | 0.019x | +133.98% |
| 2001-12-31 | $46.83 Million | $-2.56 Million | -0.055x | +40.35% |
| 2000-12-31 | $58.67 Million | $-5.37 Million | -0.092x | -199.42% |
| 1999-12-31 | $53.20 Million | $4.90 Million | 0.092x | +4.10% |
| 1998-12-31 | $48.60 Million | $4.30 Million | 0.088x | -47.84% |
| 1997-12-31 | $44.80 Million | $7.60 Million | 0.170x | -26.95% |
| 1996-12-31 | $36.60 Million | $8.50 Million | 0.232x | +33.31% |
| 1995-12-31 | $28.70 Million | $5.00 Million | 0.174x | -4.18% |
| 1994-12-31 | $22.00 Million | $4.00 Million | 0.182x | +318.18% |
| 1993-12-31 | $12.00 Million | $-1.00 Million | -0.083x | +80.38% |
| 1992-12-31 | $7.30 Million | $-3.10 Million | -0.425x | +62.73% |
| 1991-12-31 | $4.30 Million | $-4.90 Million | -1.140x | -13.95% |
| 1990-12-31 | $100.00K | $-100.00K | -1.000x | -- |
About STAAR Surgical Company
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serve… Read more